IDEAS home Printed from https://ideas.repec.org/a/spr/drugsa/v39y2016i5d10.1007_s40264-016-0393-1.html
   My bibliography  Save this article

An Integrative Data Science Pipeline to Identify Novel Drug Interactions that Prolong the QT Interval

Author

Listed:
  • Tal Lorberbaum

    (Columbia University
    Columbia University
    Columbia University)

  • Kevin J. Sampson

    (Columbia University)

  • Raymond L. Woosley

    (AZCERT, Inc.)

  • Robert S. Kass

    (Columbia University)

  • Nicholas P. Tatonetti

    (Columbia University
    Columbia University
    Observational Health Data Science and Informatics)

Abstract

Introduction Drug-induced prolongation of the QT interval on the electrocardiogram (long QT syndrome, LQTS) can lead to a potentially fatal ventricular arrhythmia known as torsades de pointes (TdP). Over 40 drugs with both cardiac and non-cardiac indications are associated with increased risk of TdP, but drug–drug interactions contributing to LQTS (QT-DDIs) remain poorly characterized. Traditional methods for mining observational healthcare data are poorly equipped to detect QT-DDI signals due to low reporting numbers and lack of direct evidence for LQTS. Objective We hypothesized that LQTS could be identified latently using an adverse event (AE) fingerprint of more commonly reported AEs. We aimed to generate an integrated data science pipeline that addresses current limitations by identifying latent signals for QT-DDIs in the US FDA’s Adverse Event Reporting System (FAERS) and retrospectively validating these predictions using electrocardiogram data in electronic health records (EHRs). Methods We trained a model to identify an AE fingerprint for risk of TdP for single drugs and applied this model to drug pair data to predict novel DDIs. In the EHR at Columbia University Medical Center, we compared the QTc intervals of patients prescribed the flagged drug pairs with patients prescribed either drug individually. Results We created an AE fingerprint consisting of 13 latently detected side effects. This model significantly outperformed a direct evidence control model in the detection of established interactions (p = 1.62E−3) and significantly enriched for validated QT-DDIs in the EHR (p = 0.01). Of 889 pairs flagged in FAERS, eight novel QT-DDIs were significantly associated with prolonged QTc intervals in the EHR and were not due to co-prescribed medications. Conclusions Latent signal detection in FAERS validated using the EHR presents an automated and data-driven approach for systematically identifying novel QT-DDIs. The high-confidence hypotheses flagged using this method warrant further investigation.

Suggested Citation

  • Tal Lorberbaum & Kevin J. Sampson & Raymond L. Woosley & Robert S. Kass & Nicholas P. Tatonetti, 2016. "An Integrative Data Science Pipeline to Identify Novel Drug Interactions that Prolong the QT Interval," Drug Safety, Springer, vol. 39(5), pages 433-441, May.
  • Handle: RePEc:spr:drugsa:v:39:y:2016:i:5:d:10.1007_s40264-016-0393-1
    DOI: 10.1007/s40264-016-0393-1
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40264-016-0393-1
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1007/s40264-016-0393-1?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Sara Hult & Daniele Sartori & Tomas Bergvall & Sara Hedfors Vidlin & Birgitta Grundmark & Johan Ellenius & G. Niklas Norén, 2020. "A Feasibility Study of Drug–Drug Interaction Signal Detection in Regular Pharmacovigilance," Drug Safety, Springer, vol. 43(8), pages 775-785, August.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:drugsa:v:39:y:2016:i:5:d:10.1007_s40264-016-0393-1. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/40264 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.